Life sciences consultancy Primecore has announced a significant transformation following its acquisition by a team of former executives from DPS Group. The new ownership aims to hire 100 people in various roles over the next three years, marking a substantial expansion in the company’s operations.
Founded in 2008, Primecore specializes in developing operational strategies for the biopharmaceutical sector. Its services encompass product and pipeline programme management, manufacturing, supply chain management, capital projects, and strategic initiative delivery. The company has a notable presence in both Ireland and the United States, with offices located in Cork, Dublin, Philadelphia, and Boston.
The first phase of recruitment will prioritize experienced specialists in capital project delivery, project management, and senior consultancy roles. This strategic hiring is intended to support Primecore’s increasing demand in the life sciences industry. Immediate recruitment efforts are underway, and interested candidates can find more information on the Primecore Careers page.
As part of their growth strategy, the new management team is targeting an increase in annual revenues from $12 million to $30 million by 2028. Currently, approximately 80 percent of Primecore’s revenue is generated from the US market. While the new investment will primarily focus on this area, the company also plans to enhance its presence in Ireland and across Europe.
Aidan O’Dwyer, who previously served as president of US project operations at DPS Group, has been appointed as Chief Executive Officer of Primecore. Eddie Kent, former Chief Financial Officer of DPS Group, joins as Chief Financial Officer, while Donal Roche, the former chair of DPS Group, assumes the role of chair on the Primecore board. Dara Kernan, the managing partner of Primecore, will continue in his current capacity.
Kernan expressed optimism about the acquisition, stating that it would enable the company to enhance its capabilities, attract top talent, and expand internationally. “We acquired Primecore because it has an outstanding reputation and represents everything we value; trusted client relationships, exceptional staff, and a proven record of delivery,” O’Dwyer commented. He added, “At the company’s core is a deep conviction that adherence to best practices, coupled with industry-leading expertise, translates capital investments into commercial success for our clients.”
The acquisition and subsequent investment signal a commitment to strengthening Primecore’s position in the life sciences sector. As the company embarks on this new chapter, it aims to tap into advanced technologies, including semiconductors and other high-growth sectors, further broadening its expertise and service offerings.
In a competitive market, Primecore’s strategic moves could position it for substantial growth in the coming years, with an emphasis on delivering exceptional value to its clients.
